Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT04740021 · UNKNOWN
Trial details
- NCT number
- NCT04740021
- Sponsor
- Taizhou HoudeAoke Biomedical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-02
- Primary completion
- 2022-02-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.